NEWSBRIEF: Incyte Genomics Posts Shrunken Q1 Revenue, Widened Loss | GenomeWeb

NEW YORK, May. 1 - Incyte Genomics today posted a wider first-quarter loss and blamed falling subscription and licensing revenue.

Revenue fell to $29 million from $51 million after the firm discontinued its custom genomic product lines last October, the company said.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.